Lyra Therapeutics (LYRA) Prepaid Assets (2019 - 2025)
Lyra Therapeutics (LYRA) recorded quarterly Prepaid Assets of $379000.0 in Q4 2025, down 60.68% on a QoQ basis from $964000.0 in Q3 2025, and down 84.52% YoY from $2.4 million in Q4 2024.
Lyra Therapeutics (LYRA) Prepaid Assets (2019 - 2025) Analysis & Trends
Lyra Therapeutics (LYRA) has reported Prepaid Assets for 7 consecutive years, with $379000.0 the latest figure, recorded in Q4 2025.
- Prepaid Assets for Q4 2025 came in at $379000.0, down 84.52% year-over-year; the trailing twelve-month figure through Dec 2025 was $379000.0 (down 84.52% YoY), and the FY2025 annual result was $379000.0, down 84.52% from the prior year.
- Prepaid Assets for Q4 2025 stood at $379000.0, down from $964000.0 in the prior quarter.
- The five-year high for Prepaid Assets was $2.9 million in Q4 2022, with the low at $379000.0 in Q4 2025.
- A 5-year average of $1.9 million and a median of $2.1 million in 2023 frame the typical range for Prepaid Assets.
- Across the five-year window, Prepaid Assets jumped 325.26% in 2021 and plunged 84.52% in 2025, its largest moves.
- Lyra Therapeutics' Prepaid Assets stood at $2.2 million in 2021, then soared by 35.19% to $2.9 million in 2022, then declined by 29.54% to $2.1 million in 2023, then grew by 18.38% to $2.4 million in 2024, then sank by 84.52% to $379000.0 in 2025.
- The last three Prepaid Assets figures came in at $379000.0 (Q4 2025), $964000.0 (Q3 2025), and $1.3 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Lyra Therapeutics | 70,995.28 | 70,995.28 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 379,000.00 |
| Sep 30, 2025 | 964,000.00 |
| Jun 30, 2025 | 1.28 Mn |
| Mar 31, 2025 | 2.17 Mn |
| Dec 31, 2024 | 2.45 Mn |
| Sep 30, 2024 | 2.82 Mn |
| Jun 30, 2024 | 1.94 Mn |
| Mar 31, 2024 | 2.33 Mn |
| Dec 31, 2023 | 2.07 Mn |
| Sep 30, 2023 | 2.37 Mn |
| Jun 30, 2023 | 1.80 Mn |
| Mar 31, 2023 | 2.09 Mn |
| Dec 31, 2022 | 2.94 Mn |
| Sep 30, 2022 | 2.34 Mn |
| Jun 30, 2022 | 1.38 Mn |
| Mar 31, 2022 | 1.80 Mn |
| Dec 31, 2021 | 2.17 Mn |
| Sep 30, 2021 | 2.76 Mn |
| Jun 30, 2021 | 1.03 Mn |
| Mar 31, 2021 | 1.25 Mn |